Results 191 to 200 of about 3,613,281 (296)
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci+6 more
wiley +1 more source
A functional approach reveals cross-system bottom-up control on coral reefs. [PDF]
Tebbett SB, Ling SD.
europepmc +1 more source
The biology of the garden centipede,Scutigerella immaculata
A. E. Michelbacher
openalex +2 more sources
Landscape of BRAF transcript variants in human cancer
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda+5 more
wiley +1 more source
Nuances in the control of separase activity between mitosis and meiosis. [PDF]
Anger M.
europepmc +1 more source
Inorganic carbon enrichment does not increase production of polyunsaturated aldehydes in a pelagic and benthic diatom. [PDF]
Johnson JP+3 more
europepmc +1 more source
From Comte to Benjamin Kidd: The appeal to biology or evolution for human guidance.
Robert Mackintosh
openalex +2 more sources
Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren+16 more
wiley +1 more source
A new fresh-water amphipod from Virginia, with some notes on its biology
George C. Embody
openalex +2 more sources